JP2008504278A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008504278A5 JP2008504278A5 JP2007518299A JP2007518299A JP2008504278A5 JP 2008504278 A5 JP2008504278 A5 JP 2008504278A5 JP 2007518299 A JP2007518299 A JP 2007518299A JP 2007518299 A JP2007518299 A JP 2007518299A JP 2008504278 A5 JP2008504278 A5 JP 2008504278A5
- Authority
- JP
- Japan
- Prior art keywords
- methylpropanoyl
- spiro
- benzofuran
- pyrrolidin
- chlorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000753 cycloalkyl group Chemical group 0.000 claims 42
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 42
- 150000001875 compounds Chemical class 0.000 claims 41
- 125000003118 aryl group Chemical group 0.000 claims 38
- 125000000217 alkyl group Chemical group 0.000 claims 37
- 125000001072 heteroaryl group Chemical group 0.000 claims 26
- 125000005843 halogen group Chemical group 0.000 claims 22
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 18
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 18
- 229910052760 oxygen Inorganic materials 0.000 claims 18
- 229910052717 sulfur Inorganic materials 0.000 claims 14
- 125000003710 aryl alkyl group Chemical group 0.000 claims 13
- 229910052799 carbon Inorganic materials 0.000 claims 13
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 12
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 12
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 125000003282 alkyl amino group Chemical group 0.000 claims 11
- 125000004663 dialkyl amino group Chemical group 0.000 claims 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 11
- 125000005466 alkylenyl group Chemical group 0.000 claims 10
- 125000004432 carbon atom Chemical group C* 0.000 claims 10
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 10
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 9
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 8
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- -1 3- (trifluoromethyl) -phenyl Chemical group 0.000 claims 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 6
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 4
- 125000005015 aryl alkynyl group Chemical group 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000004447 heteroarylalkenyl group Chemical group 0.000 claims 4
- 125000005312 heteroarylalkynyl group Chemical group 0.000 claims 4
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 4
- ATQVDTHJHUFVMS-UHFFFAOYSA-N 1'-[2-(4-chlorophenyl)-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 ATQVDTHJHUFVMS-UHFFFAOYSA-N 0.000 claims 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- UODMYZNRUHKUJO-NRFANRHFSA-N (3r)-1'-[2-(2,4-dichlorophenoxy)-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)OC1=CC=C(Cl)C=C1Cl UODMYZNRUHKUJO-NRFANRHFSA-N 0.000 claims 2
- OCYPMIJRVBVYSZ-NRFANRHFSA-N (3r)-1'-[2-(4-chlorophenoxy)-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)OC1=CC=C(Cl)C=C1 OCYPMIJRVBVYSZ-NRFANRHFSA-N 0.000 claims 2
- ATQVDTHJHUFVMS-NRFANRHFSA-N (3r)-1'-[2-(4-chlorophenyl)-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)C1=CC=C(Cl)C=C1 ATQVDTHJHUFVMS-NRFANRHFSA-N 0.000 claims 2
- 125000006648 (C1-C8) haloalkyl group Chemical group 0.000 claims 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- WQFSFVIUMVGPLM-UHFFFAOYSA-N 1'-[2-[4-(4-fluorophenyl)phenoxy]-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C(C)(C)OC(C=C1)=CC=C1C1=CC=C(F)C=C1 WQFSFVIUMVGPLM-UHFFFAOYSA-N 0.000 claims 2
- KAHYZHUJHHQKIT-UHFFFAOYSA-N 1'-[2-methyl-2-(4-pyridin-2-ylphenoxy)propanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C(C)(C)OC(C=C1)=CC=C1C1=CC=CC=N1 KAHYZHUJHHQKIT-UHFFFAOYSA-N 0.000 claims 2
- XTJCDJOXIGHEGM-UHFFFAOYSA-N 2-[4-(2-methyl-1-oxo-1-spiro[1h-2-benzofuran-3,3'-pyrrolidine]-1'-ylpropan-2-yl)oxyphenyl]acetonitrile Chemical compound C1CC2(C3=CC=CC=C3CO2)CN1C(=O)C(C)(C)OC1=CC=C(CC#N)C=C1 XTJCDJOXIGHEGM-UHFFFAOYSA-N 0.000 claims 2
- KUUUQRYJGLQMNG-UHFFFAOYSA-N 2-[4-[2-methyl-1-oxo-1-(3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-yl)propan-2-yl]oxyphenyl]acetonitrile Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C(C)(C)OC1=CC=C(CC#N)C=C1 KUUUQRYJGLQMNG-UHFFFAOYSA-N 0.000 claims 2
- HDSHKTDCDJGBTD-UHFFFAOYSA-N 4-[2-methyl-1-oxo-1-(3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-yl)propan-2-yl]oxybenzonitrile Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C(C)(C)OC1=CC=C(C#N)C=C1 HDSHKTDCDJGBTD-UHFFFAOYSA-N 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 2
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000005356 cycloalkylalkenyl group Chemical group 0.000 claims 2
- 125000005357 cycloalkylalkynyl group Chemical group 0.000 claims 2
- 125000005114 heteroarylalkoxy group Chemical group 0.000 claims 2
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 claims 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- QPVPSYUMCRZFBK-FQEVSTJZSA-N (1r)-1'-[2-(4-chlorophenyl)-2-methylpropanoyl]spiro[furo[3,4-c]pyridine-1,3'-pyrrolidine]-3-one Chemical compound C([C@@]1(CC2)C3=CC=NC=C3C(=O)O1)N2C(=O)C(C)(C)C1=CC=C(Cl)C=C1 QPVPSYUMCRZFBK-FQEVSTJZSA-N 0.000 claims 1
- SHTGXPCSYKYFQC-NRFANRHFSA-N (3r)-1'-(2-methyl-2-phenoxypropanoyl)spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)OC1=CC=CC=C1 SHTGXPCSYKYFQC-NRFANRHFSA-N 0.000 claims 1
- WHTOUDPYVXVMCR-FQEVSTJZSA-N (3r)-1'-(2-methyl-2-pyridin-3-ylpropanoyl)spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)C1=CC=CN=C1 WHTOUDPYVXVMCR-FQEVSTJZSA-N 0.000 claims 1
- WKQZRRUPYUBDNC-NRFANRHFSA-N (3r)-1'-[2-(3,4-dichlorophenoxy)-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)OC1=CC=C(Cl)C(Cl)=C1 WKQZRRUPYUBDNC-NRFANRHFSA-N 0.000 claims 1
- XJOUTPBUJBTIQV-QFIPXVFZSA-N (3r)-1'-[2-(4-chloro-2-methylphenoxy)-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound CC1=CC(Cl)=CC=C1OC(C)(C)C(=O)N1C[C@]2(C3=CC=CC=C3C(=O)O2)CC1 XJOUTPBUJBTIQV-QFIPXVFZSA-N 0.000 claims 1
- WPQOTWRUSHIAGI-NRFANRHFSA-N (3r)-1'-[2-(4-chloro-3-fluorophenoxy)-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)OC1=CC=C(Cl)C(F)=C1 WPQOTWRUSHIAGI-NRFANRHFSA-N 0.000 claims 1
- CYIOSJYCVGCCNI-MHZLTWQESA-N (3r)-1'-[2-[4-(4-acetylpiperazin-1-yl)phenyl]-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CN(C(=O)C)CCN1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C=C1 CYIOSJYCVGCCNI-MHZLTWQESA-N 0.000 claims 1
- QISWPTPETJRXDN-LJAQVGFWSA-N (3r)-1'-[2-[4-(4-butylsulfonylpiperazin-1-yl)phenyl]-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CN(S(=O)(=O)CCCC)CCN1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C=C1 QISWPTPETJRXDN-LJAQVGFWSA-N 0.000 claims 1
- XBKRVULTJYHCTL-MHZLTWQESA-N (3r)-1'-[2-[4-(4-ethylsulfonylpiperazin-1-yl)phenyl]-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CN(S(=O)(=O)CC)CCN1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C=C1 XBKRVULTJYHCTL-MHZLTWQESA-N 0.000 claims 1
- QTBLOBNFNZPKFF-LJAQVGFWSA-N (3r)-1'-[2-[4-[4-(cyclopropanecarbonyl)piperazin-1-yl]phenyl]-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)C(C=C1)=CC=C1N(CC1)CCN1C(=O)C1CC1 QTBLOBNFNZPKFF-LJAQVGFWSA-N 0.000 claims 1
- WKMNTSOSEMOOSV-NRFANRHFSA-N (3r)-1'-[2-[4-chloro-3-(trifluoromethyl)phenoxy]-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)OC1=CC=C(Cl)C(C(F)(F)F)=C1 WKMNTSOSEMOOSV-NRFANRHFSA-N 0.000 claims 1
- OARNQOCYJNZBGM-UQIIZPHYSA-N (3r)-1'-[2-methyl-2-(4-piperazin-1-ylphenoxy)propanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one;hydrochloride Chemical compound Cl.C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)OC(C=C1)=CC=C1N1CCNCC1 OARNQOCYJNZBGM-UQIIZPHYSA-N 0.000 claims 1
- KAFHHDHKQMCYLH-VWLOTQADSA-N (3r)-1'-[2-methyl-2-[4-(2-oxopyrrolidin-1-yl)phenyl]propanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)C(C=C1)=CC=C1N1CCCC1=O KAFHHDHKQMCYLH-VWLOTQADSA-N 0.000 claims 1
- WKSOZARXYWMGOZ-SANMLTNESA-N (3r)-1'-[2-methyl-2-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]propanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)C(C=C1)=CC=C1N1CCN(S(C)(=O)=O)CC1 WKSOZARXYWMGOZ-SANMLTNESA-N 0.000 claims 1
- ZYAMOJQZDATXKO-NDEPHWFRSA-N (3r)-1'-[2-methyl-2-[4-(4-propanoylpiperazin-1-yl)phenyl]propanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CN(C(=O)CC)CCN1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C=C1 ZYAMOJQZDATXKO-NDEPHWFRSA-N 0.000 claims 1
- OSAGKDILXRGDAP-NRFANRHFSA-N (3r)-1'-[2-methyl-2-[4-(trifluoromethyl)phenoxy]propanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)OC1=CC=C(C(F)(F)F)C=C1 OSAGKDILXRGDAP-NRFANRHFSA-N 0.000 claims 1
- RFBWJNWKFHATCE-LJAQVGFWSA-N (3r)-1'-[2-methyl-2-[4-[4-(2-methylpropanoyl)piperazin-1-yl]phenyl]propanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CN(C(=O)C(C)C)CCN1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C=C1 RFBWJNWKFHATCE-LJAQVGFWSA-N 0.000 claims 1
- VJOXVBDGUVIAHF-QFIPXVFZSA-N (3r)-1'-[3-(4-chlorophenyl)-2,2-dimethylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C([C@@]1(CC2)C3=CC=CC=C3C(=O)O1)N2C(=O)C(C)(C)CC1=CC=C(Cl)C=C1 VJOXVBDGUVIAHF-QFIPXVFZSA-N 0.000 claims 1
- XSXBMTIKWSOBJL-UHFFFAOYSA-N 1'-(2-methyl-2-phenylsulfanylpropanoyl)spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C(C)(C)SC1=CC=CC=C1 XSXBMTIKWSOBJL-UHFFFAOYSA-N 0.000 claims 1
- FTAZPXUDJIEEOG-UHFFFAOYSA-N 1'-[2-(4-chlorophenoxy)-2-methylpropanoyl]-7-fluorospiro[furo[3,4-c]pyridine-1,3'-pyrrolidine]-3-one Chemical compound C1CC2(C3=C(F)C=NC=C3C(=O)O2)CN1C(=O)C(C)(C)OC1=CC=C(Cl)C=C1 FTAZPXUDJIEEOG-UHFFFAOYSA-N 0.000 claims 1
- FJMMQAIXYYITHQ-UHFFFAOYSA-N 1'-[2-(4-chlorophenoxy)-2-methylpropanoyl]spiro[furo[3,4-c]pyridine-1,3'-pyrrolidine]-3-one Chemical compound C1CC2(C3=CC=NC=C3C(=O)O2)CN1C(=O)C(C)(C)OC1=CC=C(Cl)C=C1 FJMMQAIXYYITHQ-UHFFFAOYSA-N 0.000 claims 1
- MADYXNAGNKDPJM-UHFFFAOYSA-N 1'-[2-(4-chlorophenyl)-2-methylpropanoyl]spiro[furo[3,4-b]pyridine-5,3'-pyrrolidine]-7-one Chemical compound C1CC2(C3=CC=CN=C3C(=O)O2)CN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 MADYXNAGNKDPJM-UHFFFAOYSA-N 0.000 claims 1
- QPVPSYUMCRZFBK-UHFFFAOYSA-N 1'-[2-(4-chlorophenyl)-2-methylpropanoyl]spiro[furo[3,4-c]pyridine-1,3'-pyrrolidine]-3-one Chemical compound C1CC2(C3=CC=NC=C3C(=O)O2)CN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 QPVPSYUMCRZFBK-UHFFFAOYSA-N 0.000 claims 1
- UNNPELYFYFEOQG-UHFFFAOYSA-N 1'-[2-(4-chlorophenyl)sulfanyl-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C(C)(C)SC1=CC=C(Cl)C=C1 UNNPELYFYFEOQG-UHFFFAOYSA-N 0.000 claims 1
- HYLXSIXWZDGVCD-UHFFFAOYSA-N 1'-[2-[(2-chlorophenyl)methylsulfanyl]-2-methylpropanoyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C(C)(C)SCC1=CC=CC=C1Cl HYLXSIXWZDGVCD-UHFFFAOYSA-N 0.000 claims 1
- FPZZQJXSHICZJG-UHFFFAOYSA-N 1-(1,3,3a,4,5,9b-hexahydrobenzo[e]isoindol-2-yl)-2-(4-chlorophenyl)-2-methylpropan-1-one Chemical compound C1C2CCC3=CC=CC=C3C2CN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 FPZZQJXSHICZJG-UHFFFAOYSA-N 0.000 claims 1
- BXXWSPXPCHFATD-UHFFFAOYSA-N 1-(1,3,3a,4,5,9b-hexahydrobenzo[e]isoindol-2-yl)-2-[(2-chlorophenyl)methylsulfanyl]-2-methylpropan-1-one Chemical compound C1C2CCC3=CC=CC=C3C2CN1C(=O)C(C)(C)SCC1=CC=CC=C1Cl BXXWSPXPCHFATD-UHFFFAOYSA-N 0.000 claims 1
- NKNZXAVPKLICKD-UHFFFAOYSA-N 1-(1,3,3a,4,5,9b-hexahydrobenzo[e]isoindol-2-yl)-2-methyl-2-phenylsulfanylpropan-1-one Chemical compound C1C2CCC3=CC=CC=C3C2CN1C(=O)C(C)(C)SC1=CC=CC=C1 NKNZXAVPKLICKD-UHFFFAOYSA-N 0.000 claims 1
- XUHUPPIWAHHSPH-UHFFFAOYSA-N 1-(3,3a,4,9b-tetrahydro-1h-chromeno[3,4-c]pyrrol-2-yl)-2-(4-chlorophenyl)-2-methylpropan-1-one Chemical compound C1C2COC3=CC=CC=C3C2CN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 XUHUPPIWAHHSPH-UHFFFAOYSA-N 0.000 claims 1
- OJYHKAKOEVHLFT-UHFFFAOYSA-N 1-(3,4-dihydro-1h-isoquinolin-2-yl)-2-methyl-2-phenylsulfanylpropan-1-one Chemical compound C1CC2=CC=CC=C2CN1C(=O)C(C)(C)SC1=CC=CC=C1 OJYHKAKOEVHLFT-UHFFFAOYSA-N 0.000 claims 1
- CWHBIQYCDHYJHZ-UHFFFAOYSA-N 1-(5,7-dihydro-4h-thieno[2,3-c]pyridin-6-yl)-2-methyl-2-phenylsulfanylpropan-1-one Chemical compound C1CC=2C=CSC=2CN1C(=O)C(C)(C)SC1=CC=CC=C1 CWHBIQYCDHYJHZ-UHFFFAOYSA-N 0.000 claims 1
- HXMVJVGBGOOARQ-UHFFFAOYSA-N 1-(azepan-1-yl)-2-(4-chlorophenyl)-2-methylpropan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N1CCCCCC1 HXMVJVGBGOOARQ-UHFFFAOYSA-N 0.000 claims 1
- VWJSJMJXFRGAAE-HUUCEWRRSA-N 1-[(4ar,8as)-3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl]-2-(4-chlorophenyl)sulfanyl-2-methylpropan-1-one Chemical compound C([C@H]1CCCC[C@@H]1CC1)N1C(=O)C(C)(C)SC1=CC=C(Cl)C=C1 VWJSJMJXFRGAAE-HUUCEWRRSA-N 0.000 claims 1
- CQHBTIPERVSBFF-UHFFFAOYSA-N 1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2-(3,4-dichlorophenyl)-2-methylpropan-1-one Chemical compound C=1C=C(Cl)C(Cl)=CC=1C(C)(C)C(=O)N(C1)CCC1C1=CC=CC(Cl)=C1 CQHBTIPERVSBFF-UHFFFAOYSA-N 0.000 claims 1
- WOTTZQOYHYRMDU-UHFFFAOYSA-N 1-[3-(3-fluorophenyl)pyrrolidin-1-yl]-2-methyl-2-phenylsulfanylpropan-1-one Chemical compound C1CC(C=2C=C(F)C=CC=2)CN1C(=O)C(C)(C)SC1=CC=CC=C1 WOTTZQOYHYRMDU-UHFFFAOYSA-N 0.000 claims 1
- ZVVNIPPVESSVDM-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-2-methyl-1-(3-pyridin-4-ylpyrrolidin-1-yl)propan-1-one Chemical compound C=1C=C(Cl)C(Cl)=CC=1C(C)(C)C(=O)N(C1)CCC1C1=CC=NC=C1 ZVVNIPPVESSVDM-UHFFFAOYSA-N 0.000 claims 1
- BGSUEASIUSXTTN-UHFFFAOYSA-N 2-(3-chlorophenyl)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2-methylpropan-1-one Chemical compound C=1C=CC(Cl)=CC=1C(C)(C)C(=O)N(C1)CCC1C1=CC=CC(Cl)=C1 BGSUEASIUSXTTN-UHFFFAOYSA-N 0.000 claims 1
- FYDKTCSEGCZIFX-UHFFFAOYSA-N 2-(4-chlorophenoxy)-2-methyl-1-(3-phenylpiperazin-1-yl)propan-1-one Chemical compound C1CNC(C=2C=CC=CC=2)CN1C(=O)C(C)(C)OC1=CC=C(Cl)C=C1 FYDKTCSEGCZIFX-UHFFFAOYSA-N 0.000 claims 1
- FAWMEBZHDCWUKH-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-(3,4-dihydro-1h-isoquinolin-2-yl)-2-methylpropan-1-one Chemical compound C1CC2=CC=CC=C2CN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 FAWMEBZHDCWUKH-UHFFFAOYSA-N 0.000 claims 1
- FBRJDCHTXCXRKX-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-(5,7-dihydro-4h-thieno[2,3-c]pyridin-6-yl)-2-methylpropan-1-one Chemical compound C1CC=2C=CSC=2CN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 FBRJDCHTXCXRKX-UHFFFAOYSA-N 0.000 claims 1
- XAIDLDCSWHZGBR-GOSISDBHSA-N 2-(4-chlorophenyl)-1-[(1s)-1-(hydroxymethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-2-methylpropan-1-one Chemical compound N1([C@@H](C2=CC=CC=C2CC1)CO)C(=O)C(C)(C)C1=CC=C(Cl)C=C1 XAIDLDCSWHZGBR-GOSISDBHSA-N 0.000 claims 1
- RMGIENNGZALNOR-LPHOPBHVSA-N 2-(4-chlorophenyl)-1-[(2s,4r)-2-(hydroxymethyl)-4-phenylpyrrolidin-1-yl]-2-methylpropan-1-one Chemical compound C1([C@@H]2CN([C@@H](C2)CO)C(=O)C(C)(C)C=2C=CC(Cl)=CC=2)=CC=CC=C1 RMGIENNGZALNOR-LPHOPBHVSA-N 0.000 claims 1
- OHUWRPCLWQAAMG-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[3-(3-fluorophenyl)pyrrolidin-1-yl]-2-methylpropan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(C1)CCC1C1=CC=CC(F)=C1 OHUWRPCLWQAAMG-UHFFFAOYSA-N 0.000 claims 1
- BYRIOMGYMLHHJZ-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[4-(2-fluorophenyl)-4-hydroxypiperidin-1-yl]-2-methylpropan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(CC1)CCC1(O)C1=CC=CC=C1F BYRIOMGYMLHHJZ-UHFFFAOYSA-N 0.000 claims 1
- DWOBNFWGTWJBOC-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[4-(2-methoxyphenyl)piperidin-1-yl]-2-methylpropan-1-one Chemical compound COC1=CC=CC=C1C1CCN(C(=O)C(C)(C)C=2C=CC(Cl)=CC=2)CC1 DWOBNFWGTWJBOC-UHFFFAOYSA-N 0.000 claims 1
- QDDKFNDEJZFHTB-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-(3-methyl-4-phenylpiperazin-1-yl)propan-1-one Chemical compound CC1CN(C(=O)C(C)(C)C=2C=CC(Cl)=CC=2)CCN1C1=CC=CC=C1 QDDKFNDEJZFHTB-UHFFFAOYSA-N 0.000 claims 1
- FEOQUZKYTINOOR-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-(3-phenyl-2,5-dihydropyrrol-1-yl)propan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(C1)CC=C1C1=CC=CC=C1 FEOQUZKYTINOOR-UHFFFAOYSA-N 0.000 claims 1
- BQVZKMXIUUMWSK-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-(3-phenylpiperidin-1-yl)propan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(C1)CCCC1C1=CC=CC=C1 BQVZKMXIUUMWSK-UHFFFAOYSA-N 0.000 claims 1
- LICDDBTTWYEZPH-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-(3-pyridin-3-ylpyrrolidin-1-yl)propan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(C1)CCC1C1=CC=CN=C1 LICDDBTTWYEZPH-UHFFFAOYSA-N 0.000 claims 1
- SJROIVVGTWPBJQ-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-(3-pyridin-4-ylpyrrolidin-1-yl)propan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(C1)CCC1C1=CC=NC=C1 SJROIVVGTWPBJQ-UHFFFAOYSA-N 0.000 claims 1
- YLNDDTBFMRYPPP-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-(4-methyl-4-phenylpiperidin-1-yl)propan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(CC1)CCC1(C)C1=CC=CC=C1 YLNDDTBFMRYPPP-UHFFFAOYSA-N 0.000 claims 1
- BTYPCEDFOVXVKH-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-[3-(2-phenylethyl)pyrrolidin-1-yl]propan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(C1)CCC1CCC1=CC=CC=C1 BTYPCEDFOVXVKH-UHFFFAOYSA-N 0.000 claims 1
- MZHGGRPSFLWIGQ-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-[4-(2-methylphenyl)piperidin-1-yl]propan-1-one Chemical compound CC1=CC=CC=C1C1CCN(C(=O)C(C)(C)C=2C=CC(Cl)=CC=2)CC1 MZHGGRPSFLWIGQ-UHFFFAOYSA-N 0.000 claims 1
- VIRUFSAWRHDEOD-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-[4-[2-(trifluoromethyl)phenyl]piperidin-1-yl]propan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(C)(C)C(=O)N(CC1)CCC1C1=CC=CC=C1C(F)(F)F VIRUFSAWRHDEOD-UHFFFAOYSA-N 0.000 claims 1
- YJMYOCFFMDILHN-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-methyl-1-spiro[1,3-dihydroindene-2,4'-piperidine]-1'-ylpropan-1-one Chemical compound C1CC2(CC3=CC=CC=C3C2)CCN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 YJMYOCFFMDILHN-UHFFFAOYSA-N 0.000 claims 1
- VSKSFDPLUJVMBR-UHFFFAOYSA-N 2-(4-chlorophenyl)sulfanyl-2-methyl-1-spiro[1h-2-benzofuran-3,3'-pyrrolidine]-1'-ylpropan-1-one Chemical compound C1CC2(C3=CC=CC=C3CO2)CN1C(=O)C(C)(C)SC1=CC=C(Cl)C=C1 VSKSFDPLUJVMBR-UHFFFAOYSA-N 0.000 claims 1
- ISQUIBMHKMAFCO-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylsulfanyl]-1-(3,4-dihydro-1h-isoquinolin-2-yl)-2-methylpropan-1-one Chemical compound C1CC2=CC=CC=C2CN1C(=O)C(C)(C)SCC1=CC=CC=C1Cl ISQUIBMHKMAFCO-UHFFFAOYSA-N 0.000 claims 1
- JZASZJJGCNOBSP-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylsulfanyl]-1-(5,7-dihydro-4h-thieno[2,3-c]pyridin-6-yl)-2-methylpropan-1-one Chemical compound C1CC=2C=CSC=2CN1C(=O)C(C)(C)SCC1=CC=CC=C1Cl JZASZJJGCNOBSP-UHFFFAOYSA-N 0.000 claims 1
- FVOJJOLQYKUDJZ-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylsulfanyl]-1-[3-(3-fluorophenyl)pyrrolidin-1-yl]-2-methylpropan-1-one Chemical compound C1CC(C=2C=C(F)C=CC=2)CN1C(=O)C(C)(C)SCC1=CC=CC=C1Cl FVOJJOLQYKUDJZ-UHFFFAOYSA-N 0.000 claims 1
- PMLWZUAEJFXIED-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylsulfanyl]-2-methyl-1-(3-methyl-4-phenylpiperazin-1-yl)propan-1-one Chemical compound CC1CN(C(=O)C(C)(C)SCC=2C(=CC=CC=2)Cl)CCN1C1=CC=CC=C1 PMLWZUAEJFXIED-UHFFFAOYSA-N 0.000 claims 1
- AQHCXNKKBNGMMS-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylsulfanyl]-2-methyl-1-(3-phenylpiperidin-1-yl)propan-1-one Chemical compound C1CCC(C=2C=CC=CC=2)CN1C(=O)C(C)(C)SCC1=CC=CC=C1Cl AQHCXNKKBNGMMS-UHFFFAOYSA-N 0.000 claims 1
- DOJBXPOWALPFKW-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylsulfanyl]-2-methyl-1-spiro[1,3-dihydroindene-2,4'-piperidine]-1'-ylpropan-1-one Chemical compound C1CC2(CC3=CC=CC=C3C2)CCN1C(=O)C(C)(C)SCC1=CC=CC=C1Cl DOJBXPOWALPFKW-UHFFFAOYSA-N 0.000 claims 1
- HBNGXSTZYMGILK-UHFFFAOYSA-N 2-[4-(4-fluorophenyl)phenoxy]-2-methyl-1-spiro[1h-2-benzofuran-3,3'-pyrrolidine]-1'-ylpropan-1-one Chemical compound C1CC2(C3=CC=CC=C3CO2)CN1C(=O)C(C)(C)OC(C=C1)=CC=C1C1=CC=C(F)C=C1 HBNGXSTZYMGILK-UHFFFAOYSA-N 0.000 claims 1
- JNEWDTOKSVRVMO-UHFFFAOYSA-N 2-methyl-1-(3-methyl-4-phenylpiperazin-1-yl)-2-phenylsulfanylpropan-1-one Chemical compound CC1CN(C(=O)C(C)(C)SC=2C=CC=CC=2)CCN1C1=CC=CC=C1 JNEWDTOKSVRVMO-UHFFFAOYSA-N 0.000 claims 1
- XHSMLBQYVCROMW-UHFFFAOYSA-N 2-methyl-1-(3-phenylpiperidin-1-yl)-2-phenylsulfanylpropan-1-one Chemical compound C1CCC(C=2C=CC=CC=2)CN1C(=O)C(C)(C)SC1=CC=CC=C1 XHSMLBQYVCROMW-UHFFFAOYSA-N 0.000 claims 1
- KCWKCNIYDCLWAF-UHFFFAOYSA-N 2-methyl-2-phenylsulfanyl-1-spiro[1,3-dihydroindene-2,4'-piperidine]-1'-ylpropan-1-one Chemical compound C1CC2(CC3=CC=CC=C3C2)CCN1C(=O)C(C)(C)SC1=CC=CC=C1 KCWKCNIYDCLWAF-UHFFFAOYSA-N 0.000 claims 1
- JUUDJSNOHWARRA-UHFFFAOYSA-N 3-(4-chlorophenyl)-4-[3-(3-chlorophenyl)pyrrolidin-1-yl]-3-methyl-4-oxobutanoic acid Chemical compound C=1C=C(Cl)C=CC=1C(CC(O)=O)(C)C(=O)N(C1)CCC1C1=CC=CC(Cl)=C1 JUUDJSNOHWARRA-UHFFFAOYSA-N 0.000 claims 1
- UNFIZAPUQAJUKD-UHFFFAOYSA-N 3-(4-chlorophenyl)-4-[3-(3-chlorophenyl)pyrrolidin-1-yl]-n,n,3-trimethyl-4-oxobutanamide Chemical compound C=1C=C(Cl)C=CC=1C(C)(CC(=O)N(C)C)C(=O)N(C1)CCC1C1=CC=CC(Cl)=C1 UNFIZAPUQAJUKD-UHFFFAOYSA-N 0.000 claims 1
- ROQKNQLSOLDOFU-LJAQVGFWSA-N 5-[3-fluoro-4-[2-methyl-1-oxo-1-[(1r)-3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-yl]propan-2-yl]phenyl]-n,n-dimethylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)N(C)C)=CC=C1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C(F)=C1 ROQKNQLSOLDOFU-LJAQVGFWSA-N 0.000 claims 1
- OXJXZTATVINGJI-NDEPHWFRSA-N 5-[3-fluoro-4-[2-methyl-1-oxo-1-[(1r)-3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-yl]propan-2-yl]phenyl]-n-methylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C(F)=C1 OXJXZTATVINGJI-NDEPHWFRSA-N 0.000 claims 1
- OYQJXVZNTUYVMC-NDEPHWFRSA-N 5-[3-fluoro-4-[2-methyl-1-oxo-1-[(1r)-3-oxospiro[furo[3,4-c]pyridine-1,3'-pyrrolidine]-1'-yl]propan-2-yl]phenyl]-n,n-dimethylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)N(C)C)=CC=C1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=NC=C2C(=O)O3)C(F)=C1 OYQJXVZNTUYVMC-NDEPHWFRSA-N 0.000 claims 1
- YEMBWCFCBSXMPC-MHZLTWQESA-N 5-[3-fluoro-4-[2-methyl-1-oxo-1-[(1r)-3-oxospiro[furo[3,4-c]pyridine-1,3'-pyrrolidine]-1'-yl]propan-2-yl]phenyl]-n-methylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=NC=C2C(=O)O3)C(F)=C1 YEMBWCFCBSXMPC-MHZLTWQESA-N 0.000 claims 1
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 206010070901 Diabetic dyslipidaemia Diseases 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 208000018262 Peripheral vascular disease Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 229960002478 aldosterone Drugs 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 claims 1
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- UDUQCTOLTUVCEC-HKBQPEDESA-N n,n-diethyl-5-[3-fluoro-4-[2-methyl-1-oxo-1-[(1r)-3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-yl]propan-2-yl]phenyl]pyridine-2-carboxamide Chemical compound C1=NC(C(=O)N(CC)CC)=CC=C1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C(F)=C1 UDUQCTOLTUVCEC-HKBQPEDESA-N 0.000 claims 1
- CQOZJMLEYAMHHF-PMERELPUSA-N n,n-diethyl-5-[3-fluoro-4-[2-methyl-1-oxo-1-[(1r)-3-oxospiro[furo[3,4-c]pyridine-1,3'-pyrrolidine]-1'-yl]propan-2-yl]phenyl]pyridine-2-carboxamide Chemical compound C1=NC(C(=O)N(CC)CC)=CC=C1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=NC=C2C(=O)O3)C(F)=C1 CQOZJMLEYAMHHF-PMERELPUSA-N 0.000 claims 1
- OCVXLKMNSDVSKE-LJAQVGFWSA-N n,n-dimethyl-5-[4-[2-methyl-1-oxo-1-[(1r)-3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-yl]propan-2-yl]phenyl]pyridine-2-carboxamide Chemical compound C1=NC(C(=O)N(C)C)=CC=C1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C=C1 OCVXLKMNSDVSKE-LJAQVGFWSA-N 0.000 claims 1
- WPAULJZATMOQOX-NDEPHWFRSA-N n-methyl-5-[4-[2-methyl-1-oxo-1-[(1r)-3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-yl]propan-2-yl]phenyl]pyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=CC=C(C(C)(C)C(=O)N2C[C@@]3(CC2)C2=CC=CC=C2C(=O)O3)C=C1 WPAULJZATMOQOX-NDEPHWFRSA-N 0.000 claims 1
- 125000004971 nitroalkyl group Chemical group 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000008816 organ damage Effects 0.000 claims 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- AVQXJXOBQUFQBM-UHFFFAOYSA-N tert-butyl 3-(4-chlorophenyl)-4-[3-(3-chlorophenyl)pyrrolidin-1-yl]-3-methyl-4-oxobutanoate Chemical compound C=1C=C(Cl)C=CC=1C(C)(CC(=O)OC(C)(C)C)C(=O)N(C1)CCC1C1=CC=CC(Cl)=C1 AVQXJXOBQUFQBM-UHFFFAOYSA-N 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 0 CC(C)(N(*)c1ccccc11)N(*)C1=O Chemical compound CC(C)(N(*)c1ccccc11)N(*)C1=O 0.000 description 5
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58255604P | 2004-06-24 | 2004-06-24 | |
| US63917904P | 2004-12-22 | 2004-12-22 | |
| PCT/US2005/022411 WO2006002349A1 (en) | 2004-06-24 | 2005-06-23 | Amido compounds and their use as pharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008504278A JP2008504278A (ja) | 2008-02-14 |
| JP2008504278A5 true JP2008504278A5 (enExample) | 2008-08-07 |
Family
ID=35782141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007518299A Pending JP2008504278A (ja) | 2004-06-24 | 2005-06-23 | アミド化合物およびその医薬としての使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060009471A1 (enExample) |
| EP (1) | EP1758582A4 (enExample) |
| JP (1) | JP2008504278A (enExample) |
| KR (1) | KR20070024639A (enExample) |
| AU (1) | AU2005258248A1 (enExample) |
| BR (1) | BRPI0512410A (enExample) |
| CA (1) | CA2571258A1 (enExample) |
| CR (1) | CR8796A (enExample) |
| EA (1) | EA200700118A1 (enExample) |
| EC (1) | ECSP067113A (enExample) |
| IL (1) | IL179519A (enExample) |
| MX (1) | MXPA06014572A (enExample) |
| NO (1) | NO20070372L (enExample) |
| NZ (1) | NZ551602A (enExample) |
| SG (1) | SG163518A1 (enExample) |
| WO (1) | WO2006002349A1 (enExample) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7064211B2 (en) * | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
| US7880001B2 (en) * | 2004-04-29 | 2011-02-01 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| US8415354B2 (en) * | 2004-04-29 | 2013-04-09 | Abbott Laboratories | Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US20100222316A1 (en) * | 2004-04-29 | 2010-09-02 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| TWI350168B (en) | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| MXPA06014573A (es) * | 2004-06-24 | 2007-03-12 | Incyte Corp | Compuestos amido y su uso como farmaceuticos. |
| JP2008504279A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
| EP1768954A4 (en) * | 2004-06-24 | 2008-05-28 | Incyte Corp | 2-METHYLPROPANAMIDES AND THEIR USE AS PHARMACEUTICALS |
| WO2006012227A2 (en) * | 2004-06-24 | 2006-02-02 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| BRPI0512535A (pt) * | 2004-06-24 | 2008-03-25 | Incyte Corp | compostos de piperidinas n-substituìdas, suas composições e métodos de modulações |
| CN101080226A (zh) * | 2004-08-10 | 2007-11-28 | 因塞特公司 | 酰氨基化合物及它们作为药物的用途 |
| WO2006037495A2 (en) * | 2004-10-08 | 2006-04-13 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 3, group c, member 2 (nr3c2) |
| TWI400239B (zh) * | 2004-11-10 | 2013-07-01 | Incyte Corp | 內醯胺化合物及其作為醫藥品之用途 |
| US8110581B2 (en) | 2004-11-10 | 2012-02-07 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
| CA2587153A1 (en) * | 2004-11-18 | 2006-05-26 | Incyte Corporation | Inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type 1 and methods of using the same |
| US7217838B2 (en) | 2005-01-05 | 2007-05-15 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US8198331B2 (en) | 2005-01-05 | 2012-06-12 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US7511175B2 (en) | 2005-01-05 | 2009-03-31 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US20090192198A1 (en) | 2005-01-05 | 2009-07-30 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| WO2006105127A2 (en) * | 2005-03-31 | 2006-10-05 | Takeda San Diego, Inc. | Hydroxysteroid dehydrogenase inhibitors |
| JP2009508963A (ja) * | 2005-09-21 | 2009-03-05 | インサイト・コーポレイション | アミド化合物および医薬組成物としてのその使用 |
| TW200804382A (en) * | 2005-12-05 | 2008-01-16 | Incyte Corp | Lactam compounds and methods of using the same |
| WO2007084314A2 (en) * | 2006-01-12 | 2007-07-26 | Incyte Corporation | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| TW200734313A (en) | 2006-01-17 | 2007-09-16 | Astrazeneca Ab | Piperazines and piperidines as mGluR5 potentiators |
| TW200804341A (en) * | 2006-01-31 | 2008-01-16 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| JP2009526059A (ja) | 2006-02-07 | 2009-07-16 | ワイス | １１−ベータｈｓｄ１阻害剤 |
| US8119115B2 (en) | 2006-02-09 | 2012-02-21 | Gojo Industries, Inc. | Antiviral method |
| US9629361B2 (en) | 2006-02-09 | 2017-04-25 | Gojo Industries, Inc. | Composition and method for pre-surgical skin disinfection |
| WO2007101270A1 (en) * | 2006-03-02 | 2007-09-07 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| WO2007103719A2 (en) * | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| WO2007130898A1 (en) | 2006-05-01 | 2007-11-15 | Incyte Corporation | TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| CA2652375A1 (en) * | 2006-05-17 | 2007-11-29 | Incyte Corporation | Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same |
| WO2008024497A2 (en) * | 2006-08-25 | 2008-02-28 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| CL2008001839A1 (es) | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
| ATE554078T1 (de) | 2007-07-26 | 2012-05-15 | Vitae Pharmaceuticals Inc | Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern |
| JP5736098B2 (ja) | 2007-08-21 | 2015-06-17 | アッヴィ・インコーポレイテッド | 中枢神経系障害を治療するための医薬組成物 |
| AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| ATE506359T1 (de) | 2007-11-30 | 2011-05-15 | Bayer Schering Pharma Ag | Heteroaryl-substituierte piperidine |
| EP2229368A1 (en) | 2007-12-11 | 2010-09-22 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| TW200934490A (en) | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
| EP2252601B1 (en) | 2008-01-24 | 2012-12-19 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| JP5730021B2 (ja) | 2008-02-15 | 2015-06-03 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤としてのシクロアルキルラクタム誘導体 |
| CA2716128A1 (en) | 2008-02-27 | 2009-09-03 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11.beta.-hydroxysteroid dehydrogenase type 1 |
| TW200944526A (en) | 2008-04-22 | 2009-11-01 | Vitae Pharmaceuticals Inc | Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| WO2009134387A1 (en) | 2008-05-01 | 2009-11-05 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| NZ588954A (en) | 2008-05-01 | 2012-08-31 | Vitae Pharmaceuticals Inc | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2729998A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| PL2324018T3 (pl) | 2008-07-25 | 2014-02-28 | Boehringer Ingelheim Int | Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1 |
| JP5390610B2 (ja) | 2008-07-25 | 2014-01-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成 |
| EP2393807B1 (en) | 2009-02-04 | 2013-08-14 | Boehringer Ingelheim International GmbH | Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1 |
| EP2404902A1 (en) | 2009-03-05 | 2012-01-11 | Shionogi&Co., Ltd. | Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
| DE102009014484A1 (de) | 2009-03-23 | 2010-09-30 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
| UA109255C2 (ru) | 2009-04-30 | 2015-08-10 | Берінгер Інгельхайм Інтернешнл Гмбх | Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1 |
| DE102009022896A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
| DE102009022892A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
| DE102009022894A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
| ES2350077B1 (es) | 2009-06-04 | 2011-11-04 | Laboratorios Salvat, S.A. | Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1. |
| WO2011011123A1 (en) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| WO2011056737A1 (en) | 2009-11-05 | 2011-05-12 | Boehringer Ingelheim International Gmbh | Novel chiral phosphorus ligands |
| EP2576570A1 (en) | 2010-05-26 | 2013-04-10 | Boehringer Ingelheim International GmbH | 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives |
| EP2582698B1 (en) | 2010-06-16 | 2016-09-14 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| WO2011161128A1 (en) | 2010-06-25 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
| KR20130137628A (ko) | 2010-11-02 | 2013-12-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 대사 장애를 치료하기 위한 약제학적 병용물 |
| EP3235813A1 (en) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo derivatives |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL130088C (enExample) * | 1960-03-14 | |||
| US3201466A (en) * | 1963-03-08 | 1965-08-17 | Gulf Oil Corp | Substituted cyclopropanecarboxanilide herbicides |
| US3666860A (en) * | 1966-12-23 | 1972-05-30 | Gerald Berkelhammer | Substituted nitroimidazolylthiadiazoles and oxadiazoles as antiprotozoal agents |
| US3849403A (en) * | 1968-04-29 | 1974-11-19 | American Home Prod | 2,3,4,5-tetrahydro-1,1,5,5-tetrasubstituted-1h-3-benzazepines |
| DE2114420A1 (de) * | 1971-03-25 | 1972-10-05 | Merck Patent Gmbh, 6100 Darmstadt | Substituierte Phenylalkanol-Derivate und Verfahren zu ihrer Herstellung |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| US3933829A (en) * | 1974-08-22 | 1976-01-20 | John Wyeth & Brother Limited | 4-Aminoquinoline derivatives |
| TR18917A (tr) * | 1974-10-31 | 1977-12-09 | Ciba Geigy Ag | 1-(bis-triflormetilfenil)-2-oksopirolidin-4-karbonik asitleri ve bunlarin tuerevleri |
| FR2312247A1 (fr) * | 1975-05-30 | 1976-12-24 | Parcor | Derives de la thieno-pyridine, leur procede de preparation et leurs applications |
| US4439606A (en) * | 1982-05-06 | 1984-03-27 | American Cyanamid Company | Antiatherosclerotic 1-piperazinecarbonyl compounds |
| JP2801269B2 (ja) * | 1989-07-10 | 1998-09-21 | キヤノン株式会社 | 化合物およびこれを含む液晶組成物およびこれを使用した液晶素子 |
| US5206240A (en) * | 1989-12-08 | 1993-04-27 | Merck & Co., Inc. | Nitrogen-containing spirocycles |
| US5852029A (en) * | 1990-04-10 | 1998-12-22 | Israel Institute For Biological Research | Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| FR2672213B1 (fr) * | 1991-02-05 | 1995-03-10 | Sanofi Sa | Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres. |
| FR2678272B1 (fr) * | 1991-06-27 | 1994-01-14 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
| FR2705343B1 (fr) * | 1993-05-17 | 1995-07-21 | Fournier Ind & Sante | Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique. |
| FR2724656B1 (fr) * | 1994-09-15 | 1996-12-13 | Adir | Nouveaux derives du benzopyranne, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2734265B1 (fr) * | 1995-05-17 | 1997-06-13 | Adir | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant |
| US5693567A (en) * | 1995-06-07 | 1997-12-02 | Xerox Corporation | Separately etching insulating layer for contacts within array and for peripheral pads |
| FR2736053B1 (fr) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
| GB9517622D0 (en) * | 1995-08-29 | 1995-11-01 | Univ Edinburgh | Regulation of intracellular glucocorticoid concentrations |
| GB9604311D0 (en) * | 1996-02-29 | 1996-05-01 | Merck & Co Inc | Inhibitors of farnesyl-protein transferase |
| KR100613176B1 (ko) * | 1999-12-03 | 2006-08-17 | 오노 야꾸힝 고교 가부시키가이샤 | 트리아자스피로[5.5]운데칸 유도체 및 이들을유효성분으로 하는 약제 |
| US6656953B2 (en) * | 2000-12-06 | 2003-12-02 | Sepracor Inc. | 4,4-Disubstituted piperidines, and methods of use thereof |
| US7102009B2 (en) * | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
| US20020147198A1 (en) * | 2001-01-12 | 2002-10-10 | Guoqing Chen | Substituted arylamine derivatives and methods of use |
| US7365205B2 (en) * | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
| US7074788B2 (en) * | 2001-11-22 | 2006-07-11 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| GB0213715D0 (en) * | 2002-06-14 | 2002-07-24 | Syngenta Ltd | Chemical compounds |
| EP1549600A1 (en) * | 2002-07-27 | 2005-07-06 | AstraZeneca AB | Ketones |
| AU2003263323A1 (en) * | 2002-09-07 | 2004-03-29 | Celltech R And D Limited | Quinazolinone derivatives |
| US20040072802A1 (en) * | 2002-10-09 | 2004-04-15 | Jingwu Duan | Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha |
| US20050256159A1 (en) * | 2002-10-11 | 2005-11-17 | Astrazeneca Ab | 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors |
| US20060019977A1 (en) * | 2002-10-18 | 2006-01-26 | Ono Pharmaceutical Co., Ltd. | Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| CA2512886A1 (en) * | 2003-02-28 | 2004-09-10 | Galderma Research & Development, S.N.C. | Ligands that modulate lxr-type receptors |
| US20040188324A1 (en) * | 2003-03-26 | 2004-09-30 | Saleh Elomari | Hydrocarbon conversion using molecular sieve SSZ-65 |
| US7652061B2 (en) * | 2003-05-20 | 2010-01-26 | Novartis A.G. | N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| JPWO2005047286A1 (ja) * | 2003-11-13 | 2007-05-31 | 小野薬品工業株式会社 | スピロ複素環化合物 |
| DE102004020908A1 (de) * | 2004-04-28 | 2005-11-17 | Grünenthal GmbH | Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen |
| TWI350168B (en) * | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| MXPA06014573A (es) * | 2004-06-24 | 2007-03-12 | Incyte Corp | Compuestos amido y su uso como farmaceuticos. |
| WO2006012227A2 (en) * | 2004-06-24 | 2006-02-02 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| BRPI0512535A (pt) * | 2004-06-24 | 2008-03-25 | Incyte Corp | compostos de piperidinas n-substituìdas, suas composições e métodos de modulações |
| EP1768954A4 (en) * | 2004-06-24 | 2008-05-28 | Incyte Corp | 2-METHYLPROPANAMIDES AND THEIR USE AS PHARMACEUTICALS |
| JP2008504279A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
| CN101080226A (zh) * | 2004-08-10 | 2007-11-28 | 因塞特公司 | 酰氨基化合物及它们作为药物的用途 |
| TWI400239B (zh) * | 2004-11-10 | 2013-07-01 | Incyte Corp | 內醯胺化合物及其作為醫藥品之用途 |
| CA2587153A1 (en) * | 2004-11-18 | 2006-05-26 | Incyte Corporation | Inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type 1 and methods of using the same |
| JP2009508963A (ja) * | 2005-09-21 | 2009-03-05 | インサイト・コーポレイション | アミド化合物および医薬組成物としてのその使用 |
| TW200804382A (en) * | 2005-12-05 | 2008-01-16 | Incyte Corp | Lactam compounds and methods of using the same |
| WO2007084314A2 (en) * | 2006-01-12 | 2007-07-26 | Incyte Corporation | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| TW200804341A (en) * | 2006-01-31 | 2008-01-16 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| WO2007101270A1 (en) * | 2006-03-02 | 2007-09-07 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| WO2007103719A2 (en) * | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| WO2007130898A1 (en) * | 2006-05-01 | 2007-11-15 | Incyte Corporation | TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 |
| CA2652375A1 (en) * | 2006-05-17 | 2007-11-29 | Incyte Corporation | Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same |
| CL2008001839A1 (es) * | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
-
2005
- 2005-06-23 KR KR1020067027142A patent/KR20070024639A/ko not_active Ceased
- 2005-06-23 CA CA002571258A patent/CA2571258A1/en not_active Abandoned
- 2005-06-23 NZ NZ551602A patent/NZ551602A/en not_active IP Right Cessation
- 2005-06-23 EA EA200700118A patent/EA200700118A1/ru unknown
- 2005-06-23 BR BRPI0512410-7A patent/BRPI0512410A/pt not_active IP Right Cessation
- 2005-06-23 EP EP05762543A patent/EP1758582A4/en not_active Withdrawn
- 2005-06-23 US US11/159,724 patent/US20060009471A1/en not_active Abandoned
- 2005-06-23 SG SG201004456-8A patent/SG163518A1/en unknown
- 2005-06-23 MX MXPA06014572A patent/MXPA06014572A/es not_active Application Discontinuation
- 2005-06-23 JP JP2007518299A patent/JP2008504278A/ja active Pending
- 2005-06-23 WO PCT/US2005/022411 patent/WO2006002349A1/en not_active Ceased
- 2005-06-23 AU AU2005258248A patent/AU2005258248A1/en not_active Abandoned
-
2006
- 2006-11-23 IL IL179519A patent/IL179519A/en not_active IP Right Cessation
- 2006-12-06 CR CR8796A patent/CR8796A/es not_active Application Discontinuation
- 2006-12-26 EC EC2006007113A patent/ECSP067113A/es unknown
-
2007
- 2007-01-19 NO NO20070372A patent/NO20070372L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008504278A5 (enExample) | ||
| JP2008504279A5 (enExample) | ||
| JP2008520700A5 (enExample) | ||
| RU2412192C2 (ru) | Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2 | |
| JP2008504274A5 (enExample) | ||
| DK1756063T3 (en) | Amido compounds and their use as pharmaceuticals | |
| JP2007536252A5 (enExample) | ||
| CA2571258A1 (en) | Amido compounds and their use as pharmaceuticals | |
| AU2004305079B2 (en) | 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors | |
| DE60124684T2 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
| AU2005306476A1 (en) | Inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 and methods of using the same | |
| RU2004113207A (ru) | Хинолиновые производные в качестве антагонистов нейропептида y | |
| WO2013185507A1 (zh) | 苯并噻嗪-4-酮衍生物及其制备方法和用途 | |
| RU2017113007A (ru) | Новые соединения пиридопиримидинона для модулирования каталитической активности гистонлизиндеметилаз (KDMS) | |
| RU2007125648A (ru) | Инденильные производные и их применение для лечения неврологических расстройств | |
| RU96115155A (ru) | N-оксиды 4-арилпиперазинов и 4-арилпиперидинов | |
| AU2020250468A1 (en) | Use of T-type calcium channel blocker for treating pruritus | |
| ZA200609236B (en) | Amido compounds and their use as pharmaceuticals | |
| CA2196845C (en) | Hydroxamic acid compounds | |
| EP4602030A1 (en) | Novel piperazine-based sulfonamides and their use as neuroprotective and/or neurorestorative agents | |
| WO2025172260A1 (en) | Nlrp3 modulators | |
| RU2019120233A (ru) | Замещенные соединения пиразола и способы их применения для лечения гиперпролиферативных заболеваний | |
| AU2012211351A1 (en) | Amido compounds and their use as pharmaceuticals | |
| CN1988908A (zh) | 酰胺基化合物和它们作为药物的用途 |